Physician profile
Eric Albright
NPI 1114989563
$4,001.43
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,827 · 2020: $174.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $2,809.57 | 2019 | |
| Amneal Pharmaceuticals LLC | $200.32 | 2019 | |
| Amgen INC. | $193.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $157.58 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $112.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $112.71 | 2019 | |
| Novo Nordisk INC | $75.89 | 2019 | |
| Abbvie INC. | $70.57 | 2019 | |
| Mannkind Corporation | $48.23 | 2019-2020 | |
| Lilly USA, LLC | $42.50 | 2019-2020 | |
| Insulet Corporation | $41.63 | 2019-2020 | |
| Medtronic Minimed, INC. | $21.62 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $21.55 | 2019 | |
| Ibsa Pharma INC. | $20.28 | 2019 | |
| Radius Health, INC. | $18.75 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.49 | 2019 | |
| Senseonics, Incorporated | $14.00 | 2019 | |
| Companion Medical, INC. | $13.47 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Albright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.